The prognostic value of the D-dimer test in cancer patients treated with and without low-molecular-weight heparin

J Thromb Haemost. 2005 Jul;3(7):1531-3. doi: 10.1111/j.1538-7836.2005.01413.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Anticoagulants / therapeutic use*
  • Blood Coagulation Tests*
  • Fibrin Fibrinogen Degradation Products / biosynthesis*
  • Humans
  • Nadroparin / therapeutic use*
  • Neoplasms / blood*
  • Neoplasms / diagnosis
  • Neoplasms / mortality
  • Placebos
  • Prognosis
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • Nadroparin
  • Placebos
  • fibrin fragment D